Literature DB >> 1735954

Neuroendocrine differentiation in adrenocortical carcinoma. New immunohistochemical findings supported by electron microscopy.

M Miettinen1.   

Abstract

Ten adrenocortical carcinomas including two tumors with clinically detectable corticosteroid production, were immunohistochemically analyzed for their intermediate filament proteins, and for neuroendocrine markers. Keratins were present in 6 of 10, vimentin in all 10, and the 68 kilodalton kD neurofilament subunit protein in 6/10 tumors. Keratins numbers 8 and 18 were most prevalent, whereas only traces of keratins 19 and 7 were found. Eight tumors were positive for synaptophysin at least focally, and 3 showed extensive positivity in more than 30% of tumor cells. The tumors showed approximately similar levels of neuron-specific enolase (NSE) expression as judged by immunohistochemistry. Chromogranin was not detected, and there was no immunoreactivity for 3 neuropeptides (calcitonin, gastrin, somatostatin). In normal adrenal cortex, neuron-specific enolase, synaptophysin and neurofilaments were restricted to the nerves seen between the cortical cells. Electron microscopy revealed clusters of dense-core granules in 4 of 5 tumors, consistent with neuroendocrine granules. These results indicate that adrenocortical carcinomas may show signs of neuroendocrine differentiation and share some features with the adrenal medullary tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1735954

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  9 in total

Review 1.  Intermediate filaments in the nervous system: implications in cancer.

Authors:  C L Ho; R K Liem
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

Review 2.  Adrenocortical carcinosarcoma: a case report and review of the literature.

Authors:  Kotaro Sasaki; Marisa Desimone; Harsha R Rao; George J Huang; Raja R Seethala
Journal:  Diagn Pathol       Date:  2010-08-05       Impact factor: 2.644

3.  N-cadherin expression in adrenal tumors: upregulation in malignant pheochromocytoma and downregulation in adrenocortical carcinoma.

Authors:  Amir Khorram-Manesh; Håkan Ahlman; Svante Jansson; Ola Nilsson
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

4.  [Diagnostic pitfalls with Cushing's syndrome].

Authors:  W Hunger-Battefeld; M Gajda; A Hansch; A Mandecka; U A Müller; G Wolf
Journal:  Internist (Berl)       Date:  2010-03       Impact factor: 0.743

5.  [123I-Metaiodobenzylguanidine- (MIBG-) scintigraphy: paradoxical positivity in an oncocytic adrenocortical carcinoma].

Authors:  B-C Padberg; T Rordorf; S L Suter; D Pfeiffer; D Wild; S Schröder
Journal:  Pathologe       Date:  2007-07       Impact factor: 0.973

6.  A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.

Authors:  G P Bernini; A Moretti; M Ferdeghini; S Ricci; C Letizia; E D'Erasmo; G F Argenio; A Salvetti
Journal:  Br J Cancer       Date:  2001-03-02       Impact factor: 7.640

7.  Rare incidence of primary adrenocortical carcinosarcoma: A case report and literature review.

Authors:  Yong-Bao Wei; Yun-Liang Gao; Hong-Tao Wu; Shi-Feng Ou-Yang; Tao Xu; Dong-Fang Mao; Jin-Rui Yang
Journal:  Oncol Lett       Date:  2014-10-24       Impact factor: 2.967

8.  A Targeted Bioinformatics Assessment of Adrenocortical Carcinoma Reveals Prognostic Implications of GABA System Gene Expression.

Authors:  Erika L Knott; Nancy J Leidenheimer
Journal:  Int J Mol Sci       Date:  2020-11-11       Impact factor: 5.923

9.  Cytodiagnosis of myxoid adrenocortical carcinoma and role of immunocytochemistry to differentiate it from renal cell carcinoma.

Authors:  Santosh Kumar Mondal; Senjuti Dasgupta; Palash Kumar Mandal; Mamata Guha Mallick Sinha
Journal:  J Cytol       Date:  2014-04       Impact factor: 1.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.